At a glance
- Originator Uriach
- Class Antiplatelets
- Mechanism of Action Platelet activating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Disseminated intravascular coagulation; Renal failure; Thrombosis
Most Recent Events
- 21 Dec 2001 Discontinued-Preclinical for Disseminated intravascular coagulation in Spain (Unknown route)
- 21 Dec 2001 Discontinued-Preclinical for Renal failure in Spain (Unknown route)
- 21 Dec 2001 Discontinued-Preclinical for Thrombosis in Spain (Unknown route)